CINECA IRIS Institutional Research Information System

CAPPELLO, EMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.420
AS - Asia 1.291
EU - Europa 1.008
SA - Sud America 188
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 58
OC - Oceania 17
Totale 6.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.351
SG - Singapore 441
IT - Italia 302
CN - Cina 282
SE - Svezia 186
HK - Hong Kong 158
BR - Brasile 145
IN - India 106
VN - Vietnam 106
DE - Germania 101
GB - Regno Unito 93
FI - Finlandia 75
FR - Francia 64
JP - Giappone 53
NL - Olanda 45
CA - Canada 33
CI - Costa d'Avorio 32
BG - Bulgaria 28
TR - Turchia 24
KR - Corea 21
PL - Polonia 19
RU - Federazione Russa 19
AU - Australia 17
MX - Messico 16
AT - Austria 15
BD - Bangladesh 15
ID - Indonesia 13
SN - Senegal 13
AR - Argentina 12
CZ - Repubblica Ceca 9
IQ - Iraq 9
IR - Iran 9
ZA - Sudafrica 9
JM - Giamaica 8
LT - Lituania 8
NG - Nigeria 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
PK - Pakistan 7
EC - Ecuador 6
ES - Italia 6
MA - Marocco 6
PE - Perù 6
UA - Ucraina 6
VE - Venezuela 6
CR - Costa Rica 5
EG - Egitto 5
JO - Giordania 5
RS - Serbia 5
CL - Cile 4
XK - ???statistics.table.value.countryCode.XK??? 4
AZ - Azerbaigian 3
CH - Svizzera 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
IE - Irlanda 3
IL - Israele 3
LV - Lettonia 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
GR - Grecia 2
KZ - Kazakistan 2
PH - Filippine 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JE - Jersey 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SO - Somalia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 6.012
Salva come PNG Salva come JPEG
Città #
Ashburn 279
Singapore 248
San Jose 176
Hong Kong 154
Santa Clara 154
Dallas 149
Shanghai 92
Los Angeles 72
Boardman 56
Munich 56
New York 50
Florence 47
Chandler 45
Beijing 42
Atlanta 41
Helsinki 38
London 37
Pisa 37
Tokyo 37
Council Bluffs 33
Abidjan 32
Hanoi 30
Sofia 28
Turku 28
Ho Chi Minh City 27
Serra 27
Mumbai 25
Kent 21
Lauterbourg 19
Massa 19
Chicago 17
Hyderabad 17
Princeton 17
Fairfield 16
Frankfurt am Main 16
Istanbul 16
San Francisco 16
Brooklyn 15
Buffalo 14
Phoenix 14
Dakar 13
Denver 13
Houston 13
Lawrence 13
Milan 13
Rome 12
Warsaw 12
Da Nang 11
Hefei 11
Medford 10
Orem 10
Amsterdam 9
Chennai 9
Memphis 9
Ogden 9
Redondo Beach 9
São Paulo 9
Washington 9
Wilmington 9
Fuzhou 8
Lagos 8
Mexico City 8
Tashkent 8
Baltimore 7
Bengaluru 7
Jakarta 7
Johannesburg 7
Miami 7
Montreal 7
Nuremberg 7
Cambridge 6
Jeju City 6
Lappeenranta 6
Philadelphia 6
Queens 6
Rio de Janeiro 6
Roubaix 6
Seoul 6
The Bronx 6
Vienna 6
Amman 5
Belgrade 5
Belo Horizonte 5
Birmingham 5
Detroit 5
Düsseldorf 5
Livorno 5
Manchester 5
Marseille 5
New Malden 5
Paris 5
Poplar 5
Prague 5
Quanzhou 5
Toronto 5
Trujillo 5
Vancouver 5
Buenos Aires 4
Cascina 4
Curitiba 4
Totale 2.698
Salva come PNG Salva come JPEG
Nome #
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 845
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 315
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 295
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 266
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 238
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 224
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 202
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 201
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 199
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 191
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 184
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 164
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 157
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 154
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 145
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 144
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 143
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 140
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 137
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 136
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 134
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 133
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 129
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 123
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 122
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 120
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 118
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 114
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 96
Communicating Drug Safety 95
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 87
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 83
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database 71
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 69
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 59
Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990–2024): A Historical Perspective 33
Totale 6.066
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022273 0 0 39 51 48 22 13 10 13 8 20 49
2022/2023318 50 71 26 12 16 22 17 4 66 0 34 0
2023/2024379 2 9 19 3 28 41 51 36 32 25 66 67
2024/20251.452 26 58 85 118 91 145 142 55 145 159 173 255
2025/20262.319 147 114 180 182 195 95 260 58 148 156 738 46
2026/20271.291 265 949 77 0 0 0 0 0 0 0 0 0
Totale 6.066